{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:18:57Z","timestamp":1771665537850,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mam.2020.100873","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T16:40:46Z","timestamp":1596300046000},"page":"100873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Iron deficiency and supplementation in heart failure and chronic kidney disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Shweta","family":"Punj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambiz","family":"Ghafourian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2020.100873_bib1","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.mam.2020.100873_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.mam.2020.100873_bib3","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"1","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2020.100873_bib4","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.118.037553","article-title":"Response by anand and Gupta to letter regarding article, \u201canemia and iron deficiency in heart failure: current concepts and emerging therapies\u201d","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.mam.2020.100873_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.mam.2020.100873_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/35042073","article-title":"Iron homeostasis: insights from genetics and animal models","volume":"1","author":"Andrews","year":"2000","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mam.2020.100873_bib7","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2020.100873_bib8","first-page":"12","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"vol. 90","author":"Avni","year":"2015"},{"key":"10.1016\/j.mam.2020.100873_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cmet.2012.10.001","article-title":"mTOR regulates cellular iron homeostasis through tristetraprolin","volume":"16","author":"Bayeva","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2020.100873_bib10","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mam.2020.100873_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.15252\/emmm.201505748","article-title":"Reduction in mitochondrial iron alleviates cardiac damage during injury","volume":"8","author":"Chang","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2020.100873_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mam.2020.100873_bib13","first-page":"3","article-title":"Erythropoietin 1991--an overview","volume":"18","author":"Eschbach","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.mam.2020.100873_bib14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1681\/ASN.2016101053","article-title":"Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia","volume":"28","author":"Fishbane","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mam.2020.100873_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2020.100873_bib16","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100873_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V75.1.102.102","article-title":"Intact transferrin receptors in human plasma and their relation to erythropoiesis","volume":"75","author":"Huebers","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100873_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mam.2020.100873_bib19","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mam.2020.100873_bib20","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mam.2020.100873_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000334939","article-title":"Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion\/infiltration","volume":"35","author":"Kamanna","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.mam.2020.100873_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jcp.10284","article-title":"Post-transcriptional expression of DMT1 in the heart of rat","volume":"196","author":"Ke","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mam.2020.100873_bib23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","article-title":"Heme levels are increased in human failing hearts","volume":"61","author":"Khechaduri","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mam.2020.100873_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/13.1.82","article-title":"Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mam.2020.100873_bib25","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1073\/pnas.1422373112","article-title":"Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function","volume":"112","author":"Lakhal-Littleton","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2020.100873_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19804","article-title":"An essential cell-autonomous role for hepcidin in cardiac iron homeostasis","volume":"5","author":"Lakhal-Littleton","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.mam.2020.100873_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","article-title":"Myocardial iron homeostasis in advanced chronic heart failure patients","volume":"159","author":"Leszek","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mam.2020.100873_bib28","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.mam.2020.100873_bib29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1523-1755.2004.00580.x","article-title":"The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure","volume":"65","author":"Lim","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.mam.2020.100873_bib30","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mam.2020.100873_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2020.100873_bib32","first-page":"279","article-title":"Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"McMurray","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.mam.2020.100873_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.mam.2020.100873_bib34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"Moretti","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100873_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","article-title":"Regulation and effects of FGF23 in chronic kidney disease","volume":"82","author":"Musgrove","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.mam.2020.100873_bib36","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mam.2020.100873_bib37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2015.05.006","article-title":"Repletion of iron stores with the use of oral iron supplementation in patients with systolic heart failure","volume":"21","author":"Niehaus","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.mam.2020.100873_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ackd.2019.05.002","article-title":"Novel oral iron therapies for iron deficiency anemia in chronic kidney disease","volume":"26","author":"Pergola","year":"2019","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.mam.2020.100873_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfu357","article-title":"Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial","volume":"30","author":"Pisani","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mam.2020.100873_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mam.2020.100873_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/clinchem\/40.5.774","article-title":"Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum","volume":"40","author":"Punnonen","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mam.2020.100873_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/nep.12940","article-title":"Intravenous iron and erythropoiesis\u2010stimulating agents in haemodialysis: a systematic review and meta\u2010analysis","volume":"22","author":"Roger","year":"2017","journal-title":"Nephrology"},{"issue":"4","key":"10.1016\/j.mam.2020.100873_bib43","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1523-1755.2001.00976.x","article-title":"Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis","volume":"60","author":"Salahudeen","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.mam.2020.100873_bib44","doi-asserted-by":"crossref","first-page":"E6291","DOI":"10.1073\/pnas.1804701115","article-title":"mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function","volume":"115","author":"Sato","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2020.100873_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mam.2020.100873_bib46","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(17)30182-5","article-title":"Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials","volume":"4","author":"Stoffel","year":"2017","journal-title":"The Lancet Haematology"},{"key":"10.1016\/j.mam.2020.100873_bib47","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0006-2952(94)90303-4","article-title":"Ultrastructural and cytochemical changes in the heart of iron-deficient rats","volume":"47","author":"Tanne","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mam.2020.100873_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.febslet.2004.12.006","article-title":"Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14","volume":"579","author":"Taylor","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mam.2020.100873_bib49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.mam.2020.100873_bib50","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.mam.2020.100873_bib51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2362.2009.02182.x","article-title":"Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy","volume":"39","author":"Weiss","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mam.2020.100873_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.mam.2020.100873_bib53","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2020.100873_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.jrn.2014.03.006","article-title":"Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis","volume":"24","author":"Yokoyama","year":"2014","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.mam.2020.100873_bib55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin--a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mam.2020.100873_bib56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.ki.5000046","article-title":"Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects","volume":"69","author":"Zheng","year":"2006","journal-title":"Kidney Int."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:13:20Z","timestamp":1758824000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299720300261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":56,"alternative-id":["S0098299720300261"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2020.100873","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron deficiency and supplementation in heart failure and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2020.100873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100873"}}